600511 国药股份
交易中 11-05 14:23:00
资讯
新帖
简况
国药股份10月30日获主力加仓2950万元 环比增加643.07%
市场透视 · 10-30
国药股份10月30日获主力加仓2950万元 环比增加643.07%
华源证券:给予国药股份买入评级
证券之星 · 10-30
华源证券:给予国药股份买入评级
国药股份10月28日遭主力抛售2048万元 环比增加288.61%
市场透视 · 10-28
国药股份10月28日遭主力抛售2048万元 环比增加288.61%
国药股份:Q3收入同比稳增 费用端持续优化
国投证券 · 10-27
国药股份:Q3收入同比稳增 费用端持续优化
华福证券:给予国药股份买入评级
证券之星 · 10-25
华福证券:给予国药股份买入评级
国药股份2024年三季报点评:Q3收入增长稳健,运营能力有所改善
华福证券 · 10-25
国药股份2024年三季报点评:Q3收入增长稳健,运营能力有所改善
10月24日国药股份跌5.78%,鹏华医疗保健股票基金重仓该股
证券之星 · 10-24
10月24日国药股份跌5.78%,鹏华医疗保健股票基金重仓该股
国药股份大跌5.03% 近半年9家券商给予买入建议
智选洞察 · 10-24
国药股份大跌5.03% 近半年9家券商给予买入建议
图解国药股份三季报:第三季度单季净利润同比增0.64%
证券之星 · 10-24
图解国药股份三季报:第三季度单季净利润同比增0.64%
国药(01099.HK)附属国药股份首九个月赚14.81亿人民币 增长1.3%
阿斯达克财经 · 10-23
国药(01099.HK)附属国药股份首九个月赚14.81亿人民币 增长1.3%
国药控股:国药股份前三季度归母净利润14.81亿元,同比增长1.3%
智通财经 · 10-23
国药控股:国药股份前三季度归母净利润14.81亿元,同比增长1.3%
国药控股(01099):国药股份(600511.SH)前三季度归母净利润14.81亿元,同比增长1.3%
智通财经网 · 10-23
国药控股(01099):国药股份(600511.SH)前三季度归母净利润14.81亿元,同比增长1.3%
国药集团中国生物旗下疫苗又降价,华兰疫苗回应:公司没有二次调整计划
21世纪经济报道 · 10-23
国药集团中国生物旗下疫苗又降价,华兰疫苗回应:公司没有二次调整计划
国药股份(600511.SH)发布前三季度业绩,净利润14.81亿元,同比增长1.3%
智通财经 · 10-23
国药股份(600511.SH)发布前三季度业绩,净利润14.81亿元,同比增长1.3%
国药股份最新公告:前三季度净利润14.81亿元 同比增长1.3%
证券之星 · 10-23
国药股份最新公告:前三季度净利润14.81亿元 同比增长1.3%
私有化告吹中国中药暴跌35%!今年港股已有13宗私有化退市
金融界 · 10-22
私有化告吹中国中药暴跌35%!今年港股已有13宗私有化退市
国药股份10月17日遭主力抛售440万元 环比增加856.52%
市场透视 · 10-17
国药股份10月17日遭主力抛售440万元 环比增加856.52%
国药股份(600511)10月14日主力资金净卖出176.29万元
证券之星 · 10-15
国药股份(600511)10月14日主力资金净卖出176.29万元
国药股份大跌5.05% 9家券商给予买入建议
智选洞察 · 10-09
国药股份大跌5.05% 9家券商给予买入建议
国药股份10月08日主力资金流出2128万元 连续5日减仓
市场透视 · 10-08
国药股份10月08日主力资金流出2128万元 连续5日减仓
加载更多
公司概况
公司名称:
国药集团药业股份有限公司
所属行业:
批发业
上市日期:
2002-11-27
主营业务:
国药集团药业股份有限公司主营业务是医药流通。公司的主要产品是批发中成药、化学药制剂、化学原料药、抗生素、生化药品。本公司已经获得了有关药品批发、零售等药品经营的有关资格证书;国药股份一直致力于树立诚信透明的资本市场形象,努力构建更加规范的现代企业制度,推动企业经营业绩再上新台阶,公司董事会科学管理、规范运作,凭借严谨的工作作风和良好的市场口碑,信披工作“零更正、零差错”,上交所考核评级为A,公司董事会再次荣获了多项市场荣誉:(1)证券日报“中国上市公司价值”评选最具社会责任上市公司“金骏马奖”。(2)中国上市公司网“上市公司诚信百佳”评选荣获“上市公司诚信百佳”。(3)中国证券报第二十届中国上市公司"金牛投资价值奖"。(4)香港大公文汇传媒集团联合北京市上市公司协会,中国证券“金紫荆”最佳上市公司奖。(5)荣获中国上市公司网“中国改革开放40周年突出贡献单位”。
发行价格:
5.00
{"stockData":{"symbol":"600511","market":"SH","secType":"STK","nameCN":"国药股份","latestPrice":32.43,"timestamp":1730787780000,"preClose":32.1,"halted":0,"volume":7412200,"delay":0,"floatShares":553000000,"shares":755000000,"eps":2.8695,"marketStatus":"交易中","marketStatusCode":2,"change":0.33,"latestTime":"11-05 14:23:00","open":32.02,"high":32.58,"low":31.52,"amount":238000000,"amplitude":0.033,"askPrice":32.43,"askSize":46,"bidPrice":32.41,"bidSize":5,"shortable":0,"etf":0,"ttmEps":2.8695,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1730790000000},"adr":0,"adjPreClose":32.1,"symbolType":"stock","openAndCloseTimeList":[[1730770200000,1730777400000],[1730782800000,1730790000000]],"highLimit":35.31,"lowLimit":28.89,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":754502998,"pbRate":1.46,"roa":"--","roe":"9.17%","epsLYR":2.8443,"committee":-0.280277,"marketValue":24469000000,"floatMarketCap":17945000000,"peRate":11.301621,"changeRate":0.0103,"turnoverRate":0.0134,"status":0},"requestUrl":"/m/hq/s/600511","defaultTab":"news","newsList":[{"id":"2479223583","title":"国药股份10月30日获主力加仓2950万元 环比增加643.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479223583","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479223583?lang=zh_cn&edition=full","pubTime":"2024-10-30 15:18","pubTimestamp":1730272701,"startTime":"0","endTime":"0","summary":"10月30日, 国药股份股价涨0.22%,报收31.24元,成交金额2.21亿元,换手率1.28%,振幅1.32%,量比0.84。国药股份今日主力资金净流入2950万元,上一交易日主力净流入397万元,今日环比增加643.07%。|10月30日主力加仓幅度前10个股||#|股票简称|主力净额占比|#|建新股份|7.54%|#|ST浩丰|5.94%|#|创意信息|5.22%|#|精伦电子|5.01%|#|合富中国|4.19%|#|凯瑞德|4.19%|#|南天信息|4.18%|#|盈方微|3.51%|#|中信海直|3.49%|#|星星科技|3.16%|国药股份所在的医药商业行业,今日主力净流出4984万元,行业排名52/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030152718ab821a11&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030152718ab821a11&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0188","BK0010","BK0097","BK0250","BK0175","BK0012","600511","BK0082","BK0185","BK0028"],"gpt_icon":0},{"id":"2479214165","title":"华源证券:给予国药股份买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2479214165","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479214165?lang=zh_cn&edition=full","pubTime":"2024-10-30 11:57","pubTimestamp":1730260651,"startTime":"0","endTime":"0","summary":"华源证券股份有限公司刘闯近期对国药股份进行研究并发布了研究报告《Q3业绩较Q2环比改善,稳健增长可期》,本报告对国药股份给出买入评级,当前股价为31.01元。国药股份为麻精特药分销及北京地区医药商业龙头,麻精药配送业 务有望保持稳健增长,同时有望受益于医药流通行业集中度提升带来的份额提升,维持公司“买入”评级。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024103000019731.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161027","600511"],"gpt_icon":0},{"id":"2478246331","title":"国药股份10月28日遭主力抛售2048万元 环比增加288.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478246331","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478246331?lang=zh_cn&edition=full","pubTime":"2024-10-28 15:17","pubTimestamp":1730099861,"startTime":"0","endTime":"0","summary":"10月28日, 国药股份股价涨0.32%,报收31.80元,成交金额2.88亿元,换手率1.64%,振幅1.48%,量比1.24。国药股份今日主力资金净流出2048万元,连续4日净流出,上一交易日主力净流出527万元,今日环比增加288.61%。该股近5个交易日下跌2.60%,主力资金累计净流出4116万元,其中3个交易日为股价上涨时净流出;近20日主力资金累计净流出1.25亿元,其中净流出天数为16日。净流出前三个股分别为老百姓、国药股份、百洋医药。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028152045a1f0fbcb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028152045a1f0fbcb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0097","BK0028","BK0250","BK0188","BK0012","BK0175","BK0010","BK0082","600511","BK0185"],"gpt_icon":0},{"id":"2478152185","title":"国药股份:Q3收入同比稳增 费用端持续优化","url":"https://stock-news.laohu8.com/highlight/detail?id=2478152185","media":"国投证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478152185?lang=zh_cn&edition=full","pubTime":"2024-10-27 00:00","pubTimestamp":1729958400,"startTime":"0","endTime":"0","summary":"事件:公司发布2024 年三季度报告。2024 年前三季度业绩稳健,费用端持续优化提升盈利水平。2024 年前三季度公司实现营业收入380.29 亿元,同比增长4.10%,归母净利润14.81 亿元,同比增长1.30%,扣非净利润14.89 亿元,同比增长4.04%;前三季度毛利率7.02%/-0.72pct,期间费用率2.27%/-0.52pct,净利率3.90%/-0.11pct。Q3 收入增长稳健,费用管控良好,受投资收益下滑及宏观经济和医疗政策等影响,利润端同比微增。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410272001239f58c46b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410272001239f58c46b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0250","BK0028","BK0010","600511","BK0188","BK0082","BK0012","BK0175","BK0097","BK0185"],"gpt_icon":0},{"id":"2478401486","title":"华福证券:给予国药股份买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2478401486","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478401486?lang=zh_cn&edition=full","pubTime":"2024-10-25 11:50","pubTimestamp":1729828210,"startTime":"0","endTime":"0","summary":"华福证券有限责任公司陈铁林,何展聪近期对国药股份进行研究并发布了研究报告《2024年三季报点评,Q3收入增长稳健,运营能力有所改善》,本报告对国药股份给出买入评级,当前股价为31.71元。最新盈利预测明细如下:该股最近90天内共有5家机构给出评级,买入评级5家;过去90天内机构目标均价为40.81。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102500017965.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600511","161027"],"gpt_icon":0},{"id":"2478470536","title":"国药股份2024年三季报点评:Q3收入增长稳健,运营能力有所改善","url":"https://stock-news.laohu8.com/highlight/detail?id=2478470536","media":"华福证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478470536?lang=zh_cn&edition=full","pubTime":"2024-10-25 11:16","pubTimestamp":1729826173,"startTime":"0","endTime":"0","summary":"母公司业绩增长稳健,投资收益影响归母净利润增速。24Q3母公司实现收入57.08亿元,同比增长9.2%,实现净利润2.41亿元,同比增长18.7%,业绩增长稳健。合并报表归母净利润增速低于收入增速或更多受投资收益影响,24Q3公司实现联营企业投资收益0.77亿元,同比减少0.31亿元,若剔除投资收益,24Q3公司实现归母净利润4.04亿元,相同口径下同比增长9.2%。运营能力有所改善,应收占比优化。24Q1-3应收账款占总资产比例为45.4%,同比减少1.7pct。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025113346ab722d80&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025113346ab722d80&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0185","BK0028","BK0188","BK0250","600511","BK0097","BK0082","BK0175","BK0012","BK0010"],"gpt_icon":0},{"id":"2477577582","title":"10月24日国药股份跌5.78%,鹏华医疗保健股票基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2477577582","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477577582?lang=zh_cn&edition=full","pubTime":"2024-10-24 16:09","pubTimestamp":1729757344,"startTime":"0","endTime":"0","summary":"证券之星消息,10月24日国药股份跌5.78%,收盘报31.63元,换手率2.45%,成交量13.56万手,成交额4.33亿元。根据2024基金Q3季报公募基金重仓股数据,重仓该股的公募基金共5家,其中持有数量最多的公募基金为鹏华医疗保健股票。鹏华医疗保健股票目前规模为5.25亿元,最新净值1.714,较上一交易日下跌0.7%,近一年下跌6.7%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102400025275.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0185","BK0028","BK0188","BK0250","600511","BK0097","BK0082","BK0175","BK0012","BK0010"],"gpt_icon":0},{"id":"2477510598","title":"国药股份大跌5.03% 近半年9家券商给予买入建议","url":"https://stock-news.laohu8.com/highlight/detail?id=2477510598","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477510598?lang=zh_cn&edition=full","pubTime":"2024-10-24 10:03","pubTimestamp":1729735423,"startTime":"0","endTime":"0","summary":"10月24日,国药股份股价大幅下跌,截至10点03分,国药股份下跌5.03%,报31.88元/股,成交1.29亿元,换手率0.72%,振幅4.32%。此外,数据统计显示,近半年内9家券商给予买入建议。资金动向截止发稿,国药股份获得主力净流出732万元,其中超大单流出211万元,大单流出519万元。最新财报显示,今年三季报,国药股份实现营业收入380.29亿元,同比增长4.10%,净利润为14.81亿元,同比增长1.30%,基本每股收益为1.96元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024100352a1e5519b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024100352a1e5519b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0010","BK0028","BK0012","BK0175","BK0250","BK0188","BK0082","BK0097","BK0185","600511"],"gpt_icon":0},{"id":"2477047559","title":"图解国药股份三季报:第三季度单季净利润同比增0.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477047559","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477047559?lang=zh_cn&edition=full","pubTime":"2024-10-24 00:36","pubTimestamp":1729701381,"startTime":"0","endTime":"0","summary":"证券之星消息,国药股份2024年三季报显示,公司主营收入380.29亿元,同比上升4.1%;归母净利润14.81亿元,同比上升1.3%;扣非净利润14.89亿元,同比上升4.04%;其中2024年第三季度,公司单季度主营收入132.72亿元,同比上升7.12%;单季度归母净利润4.81亿元,同比上升0.64%;单季度扣非净利润4.86亿元,同比上升1.22%;负债率46.25%,投资收益3.16亿元,财务费用-7366.71万元,毛利率7.02%。财报数据概要请见下图:以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102400000256.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600511"],"gpt_icon":0},{"id":"2477530728","title":"国药(01099.HK)附属国药股份首九个月赚14.81亿人民币 增长1.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477530728","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477530728?lang=zh_cn&edition=full","pubTime":"2024-10-23 23:41","pubTimestamp":1729698060,"startTime":"0","endTime":"0","summary":"国药控股(01099.HK) 公布,附属国药股份(600511.SH) 首九个月业绩,营业收入380.29亿人民币(下同),按年增加4.1%。归属股东净利润14.81亿元,增长1.3%,每股收益1.9632元。(de/d)(港股报价延迟最少十五分钟。沽空资料截至 2024-10-23 16:25。) (A股报价延迟最少十五分钟。)过往派息公布日期派息事项派息内容2024/08/23中期业绩无派息2024/04/26第一季业绩无派息2024/03/22末期业绩普通股息:人民币 0.87 (相当于港元 0.956)2023/10/27第三季业绩无派息AASTOCKS新闻","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20240710142001125_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20240710142001125_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1390547/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1197","BK1500","BK0097","BK0010","LU0640798160.USD","BK0012","600511","BK0028","BK0250","BK0082","BK0185","LU1115378108.SGD","01099","BK1515","BK0175","BK0188"],"gpt_icon":0},{"id":"2477585047","title":"国药控股:国药股份前三季度归母净利润14.81亿元,同比增长1.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477585047","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477585047?lang=zh_cn&edition=full","pubTime":"2024-10-23 19:53","pubTimestamp":1729684418,"startTime":"0","endTime":"0","summary":"国药控股(01099)发布公告,国药股份(600511.SH)于2024年前三季度实现营业收入380.285亿元(人民币,下同),同比增长4.10%;归属于上市公司股东的净利润14.81亿元,同比增长1.30%;基本每股收益 ...","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/hks/20241023/c662723291.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["600511"],"gpt_icon":0},{"id":"2477852665","title":"国药控股(01099):国药股份(600511.SH)前三季度归母净利润14.81亿元,同比增长1.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477852665","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477852665?lang=zh_cn&edition=full","pubTime":"2024-10-23 19:51","pubTimestamp":1729684270,"startTime":"0","endTime":"0","summary":"智通财经APP讯,国药控股(01099)发布公告,国药股份(600511.SH)于2024年前三季度实现营业收入380.285亿元(人民币,下同),同比增长4.10%;归属于上市公司股东的净利润14.81亿元,同比增长1.30%;基本每股收益1.9632元。更多港股重磅资讯,下载智通财经app更多港股及海外理财资讯,请点击www.zhitongcaijing.com(搜索“智通财经”);欲加入智通港股投资群,请加智通客服微信(ztcjkf)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1198293.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["01099","600511"],"gpt_icon":0},{"id":"2477558599","title":"国药集团中国生物旗下疫苗又降价,华兰疫苗回应:公司没有二次调整计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2477558599","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477558599?lang=zh_cn&edition=full","pubTime":"2024-10-23 19:21","pubTimestamp":1729682460,"startTime":"0","endTime":"0","summary":"日前,吉林省公共资源交易中心发布《关于下调部分非免疫规划疫苗挂网价格的通知》。据悉,此次下调价格的生产企业均隶属于国药集团中国生物旗下。在此之前,国药集团已经引起过一波国产疫苗降价潮。其中,流感疫苗降价潮声势最为浩大,引发多家厂商跟进降价。此次国药集团在吉林省主要针对同类疫苗的预充注射器式进行降价。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241023192145a1e3b420&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241023192145a1e3b420&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0188","BK0010","BK0097","BK0239","BK0250","BK0175","BK0012","600511","159646","BK0082","BK0185","BK0028","301207"],"gpt_icon":0},{"id":"2477306217","title":"国药股份(600511.SH)发布前三季度业绩,净利润14.81亿元,同比增长1.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477306217","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477306217?lang=zh_cn&edition=full","pubTime":"2024-10-23 17:54","pubTimestamp":1729677248,"startTime":"0","endTime":"0","summary":"智通财经APP讯,国药股份(600511.SH)披露2024年第三季度报告,报告期公司实现营收380.29亿元,同比增长4.1%;归母净利润14.81亿元,同比增长1.3%;扣非净利润14.89亿元,同比增长4.04%;基本每股收益1.9632元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1198133.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["600511"],"gpt_icon":0},{"id":"2477330600","title":"国药股份最新公告:前三季度净利润14.81亿元 同比增长1.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477330600","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477330600?lang=zh_cn&edition=full","pubTime":"2024-10-23 17:50","pubTimestamp":1729677055,"startTime":"0","endTime":"0","summary":"国药股份发布2024年第三季度报告,前三季度实现营业收入380.29亿元,同比增长4.1%;归属于上市公司股东的净利润14.81亿元,同比增长1.3%;归属于上市公司股东的扣除非经常性损益的净利润14.89亿元,同比增长4.04%。其中,第三季度实现营业收入132.72亿元,同比增长7.12%;归属于上市公司股东的净利润4.81亿元,同比增长0.64%。主要受市场环境影响,部分客户回款周期延长,带量采购品种付款压力加大,以及资金筹措结构调整所致。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102300030929.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600511"],"gpt_icon":0},{"id":"2477826879","title":"私有化告吹中国中药暴跌35%!今年港股已有13宗私有化退市","url":"https://stock-news.laohu8.com/highlight/detail?id=2477826879","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477826879?lang=zh_cn&edition=full","pubTime":"2024-10-22 08:58","pubTimestamp":1729558680,"startTime":"0","endTime":"0","summary":"10月16日,中国中药(0570.HK)发布公告指,作为私有化先决条件的境外直接投资批准和反垄断批准未能在最后截止日期(2024年10月18 日)前获得,因此私有化建议失效。中国中药股份在联交所的 ...","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/hks/20241022/c662642115.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["600129","BK0250","600420","BK0046","600511","BK0113","BK0010","BK0028","BK0020","BK0185","BK0168","BK0097","BK0132","BK0082","600161","BK0239","BK0188","BK0175","BK0012"],"gpt_icon":0},{"id":"2476716017","title":"国药股份10月17日遭主力抛售440万元 环比增加856.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2476716017","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476716017?lang=zh_cn&edition=full","pubTime":"2024-10-17 15:17","pubTimestamp":1729149440,"startTime":"0","endTime":"0","summary":"10月17日, 国药股份股价跌2.04%,报收32.21元,成交金额1.32亿元,换手率0.73%,振幅2.98%,量比0.61。国药股份今日主力资金净流出440万元,连续5日净流出,上一交易日主力净流出46万元,今日环比增加856.52%。|10月17日主力加仓幅度前10个股||#|股票简称|主力净额占比|#|N托普云农|18.37%|#|凯旺科技|5.94%|#|国华网安|5.89%|#|华扬联众|4.41%|#|任子行|4.32%|#|中广天择|4.14%|#|捷邦科技|4.09%|#|工大科雅|3.99%|#|铭普光磁|3.74%|#|软通动力|3.71%|国药股份所在的医药商业行业,今日主力净流出2793万元,行业排名67/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101715195695aed5e8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101715195695aed5e8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0010","BK0188","BK0028","BK0012","600511","BK0097","BK0175","BK0250","BK0185","BK0082"],"gpt_icon":0},{"id":"2475329177","title":"国药股份(600511)10月14日主力资金净卖出176.29万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2475329177","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475329177?lang=zh_cn&edition=full","pubTime":"2024-10-15 08:22","pubTimestamp":1728951773,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年10月14日收盘,国药股份报收于32.88元,下跌0.18%,换手率1.3%,成交量7.2万手,成交额2.37亿元。近5日资金流向一览见下表:国药股份融资融券信息显示,融资方面,当日融资买入865.87万元,融资偿还847.5万元,融资净买入18.37万元。融券方面,融券卖出4500.0股,融券偿还5500.0股,融券余量7.12万股,融券余额234.02万元。国药股份主营业务:组织药品生产;化学原料药、西药制剂、生化药品、生物制品、中成药的销售。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024101500006881.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0010","BK0028","BK0012","BK0175","BK0250","BK0188","BK0082","BK0097","BK0185","600511"],"gpt_icon":0},{"id":"2474263857","title":"国药股份大跌5.05% 9家券商给予买入建议","url":"https://stock-news.laohu8.com/highlight/detail?id=2474263857","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474263857?lang=zh_cn&edition=full","pubTime":"2024-10-09 11:06","pubTimestamp":1728443219,"startTime":"0","endTime":"0","summary":"10月09日,国药股份股价大幅下跌,截至11点06分,国药股份下跌5.05%,报33.68元/股,成交1.83亿元,换手率0.96%,振幅4.54%。此外,数据统计显示,近半年内9家券商给予买入建议。资金动向截止发稿,国药股份获得主力净流出2355万元,其中超大单流出2184万元,大单流出169万元。最新财报显示,今年中报,国药股份实现营业收入247.57亿元,同比增长2.55%,净利润为10.01亿元,同比增长1.62%,基本每股收益为1.33元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241009115810a1df4289&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241009115810a1df4289&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0028","BK0185","BK0250","BK0188","600511","BK0012","BK0175","BK0097","BK0010","BK0082"],"gpt_icon":0},{"id":"2473416578","title":"国药股份10月08日主力资金流出2128万元 连续5日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2473416578","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473416578?lang=zh_cn&edition=full","pubTime":"2024-10-08 15:17","pubTimestamp":1728371845,"startTime":"0","endTime":"0","summary":"10月08日, 国药股份股价涨2.66%,报收35.47元,成交金额5.25亿元,换手率2.64%,振幅10.16%,量比1.75。国药股份今日主力资金净流出2128万元,连续5日净流出,上一交易日主力净流出3741万元,今日环比减少43.12%。该股近5个交易日上涨18.43%,主力资金累计净流出1.00亿元;近20日主力资金累计净流入5819万元,其中净流入天数为10日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100815230895978446&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100815230895978446&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0028","BK0185","BK0250","BK0188","600511","BK0012","BK0175","BK0097","BK0010","BK0082"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2002-11-27","address":"北京市东城区永定门西滨河路8号院7楼西塔6-9层","stockEarnings":[{"period":"1week","weight":0.0094},{"period":"1month","weight":-0.0709},{"period":"3month","weight":-0.0503},{"period":"6month","weight":-0.0658},{"period":"1year","weight":0.1624},{"period":"ytd","weight":0.151}],"companyName":"国药集团药业股份有限公司","boardCode":"AI0051","perCapita":"12759股","boardName":"批发业","registeredCapital":"75450万元","compareEarnings":[{"period":"1week","weight":-0.0036},{"period":"1month","weight":-0.0079},{"period":"3month","weight":0.1545},{"period":"6month","weight":0.0581},{"period":"1year","weight":0.0922},{"period":"ytd","weight":0.1127}],"survey":" 国药集团药业股份有限公司主营业务是医药流通。公司的主要产品是批发中成药、化学药制剂、化学原料药、抗生素、生化药品。本公司已经获得了有关药品批发、零售等药品经营的有关资格证书;国药股份一直致力于树立诚信透明的资本市场形象,努力构建更加规范的现代企业制度,推动企业经营业绩再上新台阶,公司董事会科学管理、规范运作,凭借严谨的工作作风和良好的市场口碑,信披工作“零更正、零差错”,上交所考核评级为A,公司董事会再次荣获了多项市场荣誉:(1)证券日报“中国上市公司价值”评选最具社会责任上市公司“金骏马奖”。(2)中国上市公司网“上市公司诚信百佳”评选荣获“上市公司诚信百佳”。(3)中国证券报第二十届中国上市公司\"金牛投资价值奖\"。(4)香港大公文汇传媒集团联合北京市上市公司协会,中国证券“金紫荆”最佳上市公司奖。(5)荣获中国上市公司网“中国改革开放40周年突出贡献单位”。","serverTime":1730787782934,"listedPrice":5,"stockholders":"43368人(较上一季度减少3.06%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"国药股份(600511)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供国药股份(600511)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"国药股份,600511,国药股份股票,国药股份股票老虎,国药股份股票老虎国际,国药股份行情,国药股份股票行情,国药股份股价,国药股份股市,国药股份股票价格,国药股份股票交易,国药股份股票购买,国药股份股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"国药股份(600511)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供国药股份(600511)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}